Skip to main content
. Author manuscript; available in PMC: 2013 Dec 19.
Published in final edited form as: Arthritis Rheum. 2009 Oct 15;61(10):10.1002/art.24642. doi: 10.1002/art.24642

Table 3.

Univariate random-effects meta-regression assessing potential effects of selected continuous covariates in the observed pooled effect of HLA–B51/B5 on the risk of developing BD*

Variable Populations, no. df OR (95% CI) P cov
BD case characteristics
 Male sex, % 44 1 1.02 (1.004–1.03) 0.008
 Age at study time, years 20 1 1.00 (0.95–1.06) 0.96
 Age at onset/diagnosis, years 5 1 0.95 (0.70–1.29) 0.74
 Ocular involvement, % 32 1 1.01 (0.999–1.02) 0.08
 CNS involvement, % 16 1 1.02 (0.99–1.05) 0.14
 Large-vessel involvement, % 16 1 1.03 (0.99–1.07) 0.10
Year of publication 80 1 0.99 (0.98–1.01) 0.44
*

The ORs shown in the table can be interpreted as the change in the odds for any one-unit increase of the corresponding covariates. BD = Behçet’s disease; OR = odds ratio; 95% CI = 95% confidence interval; Pcov = P values for significance of covariates in the pooled genetic effect; CNS = central nervous system.